VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Sell

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Oct 24, 2023 7:44pm

80 Views

Post# 35699251

RE:Sell

I completely disagree Holdrrrr, this is not a COVID play. It's a much needed cost-saving alternative to MRI for cardiac care. I've held VPT for many years prior to COVID and continue to hold. It's too bad you didn't do much DD on the true value of VLT's tech before spouting off with your one-liner. Glad you decided to sell, but no need to announce it. I don't intend to follow your lead

<< Previous

Bullboard Posts

Next >>

Hudbay signs US$300M financing to advance B.C. copper project